Active Pharmaceutical Ingredient (API)

Rasagiline Mesylate

MAO-B Inhibitor

A newer, highly selective, and irreversible inhibitor of $\text{MAO-B}$ used for $\text{Parkinson}$'s disease. It has a high potency and is generally used as monotherapy in early disease or as an adjunct to $\text{Levodopa}$ to reduce "off" time. It does not produce amphetamine metabolites.
Technical Profile
Reference Code
RAS400
CAS Number
161533-22-6
Molecular Weight
267.34 g/mol
Chemical Class
N/A
Molecular Formula
C12H13N·CH4O3S
Therapeutic Class
N/A

Verified Brands

Medicines containing Rasagiline Mesylate as an active ingredient.

Brand Name Manufacturer Formulation MRP
No verified brands found for this salt.